Francesca Zanoni, Maddalena Marasa, Lucrezia Carlassara, Miguel Verbitsky, Atlas Khan, Chen Wang, Joshua D Bundy, Pietro A Canetta, Andrew S Bomback, Afshin Parsa, Harold I Feldman, Ali G Gharavi, Krzysztof Kiryluk
{"title":"Family History in the Context of CKD.","authors":"Francesca Zanoni, Maddalena Marasa, Lucrezia Carlassara, Miguel Verbitsky, Atlas Khan, Chen Wang, Joshua D Bundy, Pietro A Canetta, Andrew S Bomback, Afshin Parsa, Harold I Feldman, Ali G Gharavi, Krzysztof Kiryluk","doi":"10.1681/ASN.0000000653","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":" ","pages":"1561-1571"},"PeriodicalIF":9.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342073/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1681/ASN.0000000653","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
背景:健康状况的家族史可能反映了共同的遗传和/或环境风险。目前尚不清楚家族史在多大程度上影响慢性肾病(CKD)患者的预后。在此,我们研究了CKD患者中CKD家族史、糖尿病以及其他常见合并症和肾脏疾病进展的相关性。方法:我们对两个前瞻性CKD队列进行了一项观察性研究,2573名成人和儿童来自治愈肾小球网络(CureGN)和3939名慢性肾功能不全队列(CRIC)成人参与者。自我报告的CKD、糖尿病和其他常见疾病的一级家族史使用多变量模型测试了与合并症和CKD进展风险的关联。结果:常见合并症的家族史与CKD中这些疾病的高风险相关,其中糖尿病约为3倍以上(调整OR为3.37,95% ci为2.73-4.15),癌症约为48%(调整OR为1.48,95% ci为1.05-2.09),心血管疾病约为69%(调整OR为1.69,95% ci为1.36-2.10)。虽然CKD的多基因风险评分与肾脏疾病进展相关(校正HR 1.11,合并队列中95% ci 1.06-1.16),但在已有CKD的情况下,肾脏疾病家族史并不是疾病进展的独立危险因素。相比之下,糖尿病家族史与独立于糖尿病发生的较高CKD进展风险或糖尿病多基因风险评分显著相关(校正HR 1.19,合并队列95% ci 1.05-1.35)。结论:在CKD背景下广泛收集家族史可以改善临床风险分层。在两个队列中,糖尿病家族史始终与较高的CKD进展风险相关,与糖尿病状态或糖尿病多基因风险评分无关。
期刊介绍:
The Journal of the American Society of Nephrology (JASN) stands as the preeminent kidney journal globally, offering an exceptional synthesis of cutting-edge basic research, clinical epidemiology, meta-analysis, and relevant editorial content. Representing a comprehensive resource, JASN encompasses clinical research, editorials distilling key findings, perspectives, and timely reviews.
Editorials are skillfully crafted to elucidate the essential insights of the parent article, while JASN actively encourages the submission of Letters to the Editor discussing recently published articles. The reviews featured in JASN are consistently erudite and comprehensive, providing thorough coverage of respective fields. Since its inception in July 1990, JASN has been a monthly publication.
JASN publishes original research reports and editorial content across a spectrum of basic and clinical science relevant to the broad discipline of nephrology. Topics covered include renal cell biology, developmental biology of the kidney, genetics of kidney disease, cell and transport physiology, hemodynamics and vascular regulation, mechanisms of blood pressure regulation, renal immunology, kidney pathology, pathophysiology of kidney diseases, nephrolithiasis, clinical nephrology (including dialysis and transplantation), and hypertension. Furthermore, articles addressing healthcare policy and care delivery issues relevant to nephrology are warmly welcomed.